Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Just PA"'
Autor:
Marcellin, L., Santulli, P., Chouzenoux, S., Cerles, O., Nicco, C., Dousset, B., Pallardy, M., Kerdine-Römer, S., Just, PA., Chapron, C., Batteux, F.
Publikováno v:
In Free Radical Biology and Medicine September 2017 110:1-10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vercellino L, Bousquet G, Baillet G, Barré E, Mathieu O, Just PA, Desgrandchamps F, Misset JL, Hindié E, Moretti JL, Vercellino, Laetitia, Bousquet, Guilhem, Baillet, Georges, Barré, Emmanuelle, Mathieu, Olivier, Just, Pierre-Alexandre, Desgrandchamps, François, Misset, Jean-Louis, Hindié, Elif, Moretti, Jean-Luc
Publikováno v:
Cancer Biotherapy & Radiopharmaceuticals; Feb2009, Vol. 24 Issue 1, p137-144, 8p
Autor:
Cyrta J; Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL Research University, Paris, France., Brillet R; Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL Research University, Paris, France., Laas E; Department of Breast and Gynecological Surgery, Institut Curie, Université Paris Cité, Paris, France., Just PA; Department of Pathology, Assistance Publique - Hôpitaux de Marseille, Marseille, Provence-Alpes-Côte d'Azur, France., Andrianteranagna M; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, Université Paris Cité, Paris, France., Leary A; Oncology Department, Institut Gustave Roussy, Villejuif, France., Vincent-Salomon A; Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL Research University, Paris, France., Bourdeaut F; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA with Cancer), Institut Curie, Université Paris Cité, Paris, France., Masliah-Planchon J; Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL Research University, Paris, France.
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2024 Aug 02. Date of Electronic Publication: 2024 Aug 02.
Autor:
Le Saux O; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France., Ardin M; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Berthet J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Barrin S; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Bourhis M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Cinier J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Lounici Y; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France., Treilleux I; Department of Anatomopathology, Centre Léon Bérard, 69008, Lyon, France., Just PA; Department of Anatomopathology, AP-HM, Marseille, France., Bataillon G; Department of Anatomopathology, University hospital of Toulouse, Toulouse, France., Savoye AM; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Institut Jean Godinot, Reims, France., Mouret-Reynier MA; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France., Coquan E; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre François Baclesse, Caen, France., Derbel O; Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon, France., Jeay L; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France., Bouizaguen S; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France., Labidi-Galy I; Department of Oncology, Hôpitaux universitaires de Genève, Faculty of Medecine, Center of Translational Research in Onco-Hematology, Swiss Cancer Center Leman, Geneva, Switzerland., Tabone-Eglinger S; Human Biological Resources, Centre Léon Bérard, 69008, Lyon, France., Ferrari A; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France., Thomas E; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France., Ménétrier-Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Tartour E; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Galy-Fauroux I; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie, PSL Research University, 75005, Paris, France., Terme M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France., Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France., Dubois B; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr., Ray-Coquard I; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France. isabelle.ray-coquard@lyon.unicancer.fr.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 16; Vol. 15 (1), pp. 5932. Date of Electronic Publication: 2024 Jul 16.
Autor:
Hélage S; Department of Radiology, Hôtel-Dieu de Paris (AP-HP), Paris 75004, France., Rivière L; Department of Radiology, Hôtel-Dieu de Paris (AP-HP), Paris 75004, France., Buy JN; Department of Radiology, Hôtel-Dieu de Paris (AP-HP), Paris 75004, France., Bordonné C; Department of Radiology, Hôtel-Dieu de Paris (AP-HP), Paris 75004, France., Préaux F; Léonard de Vinci Medical Imaging, 43 rue Cortambert, Paris 75016, France., Just PA; Department of Pathology, Hôpital Cochin (AP-HP), Paris 75014, France., Aflak N; Department of Gynecological Surgery, Hôpital Beaujon (AP-HP), Clichy 92110, France., Rousset P; Department of Radiology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite 69495, France., Dion É; Department of Radiology, Hôtel-Dieu de Paris (AP-HP), Paris 75004, France.
Publikováno v:
The British journal of radiology [Br J Radiol] 2024 May 07; Vol. 97 (1157), pp. 993-1002.
Autor:
Boidot R; Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center - UNICANCER, Dijon, France., Blum MGB; SeqOne Genomics, Montpellier, France. Electronic address: michael.blum@seqone.com., Wissler MP; CYPATH, Villeurbanne, France., Gottin C; SeqOne Genomics, Montpellier, France., Ruzicka J; SeqOne Genomics, Montpellier, France., Chevrier S; Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center - UNICANCER, Dijon, France., Delhomme TM; SeqOne Genomics, Montpellier, France., Audoux J; SeqOne Genomics, Montpellier, France., Jeanniard A; Agilent Technologies France, Les Ulis, France., Just PA; APHM (Assistance Publique - Hôpitaux de Marseille), Service de Pathologie Hôpitaux et services de santé, Marseille, Provence-Alpes-Côte d'Azur, France., Harter P; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy., González-Martin A; Clinica Universidad de Navarra,GEICO, Madrid, Spain., Marth C; Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria., Mäenpää J; Tampere University Hospital, Department of Obstetrics and Gynecology, Finland., Colombo N; University of Milan-Bicocca and European Institute of Oncology IRCCS, Milan, Italy., Vergote I; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union., Fujiwara K; Saitama Medical University International Medical Center, Saitama, Japan., Duforet-Frebourg N; SeqOne Genomics, Montpellier, France., Bertrand D; SeqOne Genomics, Montpellier, France., Philippe N; SeqOne Genomics, Montpellier, France., Ray-Coquard I; Centre Léon BERARD, and University Claude Bernard Lyon I, Lyon and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Lyon, France., Pujade-Lauraine E; Association de Recherche Cancers Gynécologiques (ARCAGY-GINECO), Paris, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113978. Date of Electronic Publication: 2024 Mar 02.
Autor:
Croce S; Anticancer Center, Institut Bergonié, Department of BioPathology, Bordeaux, France; Unité Inserm U1312, Bordeaux, France; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France. Electronic address: s.croce@bordeaux.unicancer.fr., Devouassoux-Shisheboran M; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; CHU de Lyon, Department of Pathology, Lyon, France., Pautier P; Institut Gustave-Roussy, Department of Medical Oncology, Villejuif, France., Ray-Coquard I; Centre Leon-Berard, Department of Medical Oncology, Lyon, France; University Claude-Bernard Lyon I, Laboratoire RESHAPE U1290, Lyon, France., Treilleux I; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; Centre Leon-Berard, Department of Pathology, Lyon, France., Neuville A; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; Institut de Pathologie de Haut de France, Amiens, France., Arnould L; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; Centre G.-F.-Leclerc, Biology and Tumor Pathology Department, Dijon, France., Just PA; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; AP-HP, Hôpital Cochin, Department of Pathology, Paris, France., Le Frere Belda MA; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; AP-HP. Centre, European Georges-Pompidou Hospital, Department of Pathology, Paris, France., Averous G; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; CHRU de Strasbourg, Department of Pathology, Strasbourg, France., Leroux A; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; Institut de Cancérologie de Lorraine, Department of Pathology, Nancy, France., Bataillon G; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; CHRU de Strasbourg, Department of Pathology, Strasbourg, France., Mery E; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; IUCT Oncopole, Department of Pathology, Toulouse, France., Loussouarn D; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; CHU de Nantes, Department of Pathology, Nantes, France., Weinbreck N; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; Medipath, Fréjus, France., Le Guellec S; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; Medipath-Les Feuillants, Toulouse, France., Mishellany F; Gynecological pathology group of RRePS (Réseau de Référence en Pathologie des Sarcomes) Network, France; Centre de Lutte contre le Cancer Jean-Perrin, Department of Pathology, Clermont-Ferrand, France., Morice P; Gustave-Roussy, Department of Gynecological Surgery, Villejuif, Île-de-France, France., Guyon F; Institut Bergonié, Department of surgery, Bordeaux, France., Genestie C; Gustave-Roussy, Département de Biopathologie, Unité 981, Villejuif, France.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2024 Jan; Vol. 111 (1), pp. 97-116. Date of Electronic Publication: 2023 Oct 06.
Autor:
Neyrand S; Department of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France., Trecourt A; Department of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France.; University Claude Bernard Lyon I, Villeurbanne, France., Lopez J; University Claude Bernard Lyon I, Villeurbanne, France.; Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France., Just PA; TMRG French Network for Rare Ovarian Malignant Tumor, Paris, France.; Department of Pathology La Timone Hospital, Marseille, France., Descotes F; Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France., Borson-Chazot F; University Claude Bernard Lyon I, Villeurbanne, France.; Department of Endocrinology, Hospices Civils de Lyon, Groupement Hospitalier Est, University Claude Bernard Lyon I, Bron, France., Ray-Coquard I; University Claude Bernard Lyon I, Villeurbanne, France.; TMRG French Network for Rare Ovarian Malignant Tumor, Paris, France.; Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France., Decaussin-Petrucci M; Department of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France.; University Claude Bernard Lyon I, Villeurbanne, France., Devouassoux-Shisheboran M; Department of Pathology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France.; University Claude Bernard Lyon I, Villeurbanne, France.; TMRG French Network for Rare Ovarian Malignant Tumor, Paris, France.
Publikováno v:
Histopathology [Histopathology] 2024 Jan; Vol. 84 (2), pp. 291-300. Date of Electronic Publication: 2023 Sep 28.
Autor:
Pozzorini C; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Andre G; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Coletta T; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Buisson A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Bieler J; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Ferrer L; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Kempfer R; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Saintigny P; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Harlé A; Institut de Cancérologie de Lorraine, Service de Biopathologie, CNRS UMR 7039 CRAN, Vandoeuvre-lès-Nancy, France., Vacirca D; European Institute of Oncology, Milan, Italy., Barberis M; European Institute of Oncology, Milan, Italy., Gilson P; Institut de Cancérologie de Lorraine, Service de Biopathologie, CNRS UMR 7039 CRAN, Vandoeuvre-lès-Nancy, France., Roma C; Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy., Saitta A; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Smith E; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Consales Barras F; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Ripol L; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Fritzsche M; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Marques AC; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Alkodsi A; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Marin R; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Normanno N; Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy., Grimm C; Medical University of Vienna, Vienna, Austria., Müllauer L; Medical University of Vienna, Vienna, Austria., Harter P; Kliniken Essen Mitte, Essen, Germany., Pignata S; Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy., Gonzalez-Martin A; Cancer Center Clinica Universidad de Navarra, Madrid, Spain; GEICO, Madrid, Spain; Program In Solid Tumors, CIMA, Pamplona, Spain., Denison U; Department for Gynaecology and Obstetrics, Klinik Hietzing, Vienna, Austria., Fujiwara K; Saitama Medical University International Medical Center, Saitama, Japan., Vergote I; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium., Colombo N; European Institute of Oncology, Milan, Italy., Willig A; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland., Pujade-Lauraine E; Association de Recherche Cancers Gynécologiques (ARCAGY), Paris, France., Just PA; Service de Pathologie, APHM (Assistance Publique - Hôpitaux de Marseille), Marseille, Provence-Alpes-Côte d'Azur, France., Ray-Coquard I; Centre Léon BERARD, and University Claude Bernard Lyon I, Lyon, France; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Lyon, France., Xu Z; SOPHiA GENETICS, La Piéce 12, 1180 Rolle, Switzerland. Electronic address: zxu@sophiagenetics.com.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2023 Dec 19; Vol. 4 (12), pp. 101344.